Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 87593 

and by whom, who gets evaluated, and 

who gets placed on the organ 

transplantation waiting list. These data 

will also facilitate the OPTN’s ability to 

address disparities in processes of care, 

improve access to organ transplantation, 

and assess overall system performance. 

Once this collection is approved, 

HRSA will cease the use of the Death 

Notification Registration and the 

Deceased Donor Death Referral forms 

that are included within the existing 

OMB-approved Data System for Organ 

Procurement and Transplantation 

Network OMB No. 0915–0157. This 

decision was made to avoid unnecessary 

burden and redundancy in the data 

collected by this package and the 

existing OMB data collection 

instrument. 

Likely Respondents: Transplant 

Centers, OPOs, and Histocompatibility 

Laboratories. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form No. Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

1 ..................... Pre-Waitlist Transplant Referral Form ............. 248 1,164.68 288,840.64 0.35 101,094.22 

2 ..................... Pre-Waitlist Transplant Evaluation Form ......... 248 594.22 147,366.56 0.40 58,946.62 

3 ..................... Ventilated Patient Form ................................... 56 3,292.00 184,352.00 0.50 92,176.00 

Total ........ .......................................................................... 552 ........................ 620,559.20 .................... 252,216.84 

The average burden estimates of both 

new pre-waitlist forms are based on the 

2023 burden estimates of existing OMBapproved Transplant Candidate 

Registration forms, approved under 

0915–0157. The average burden 

estimate of the Ventilated Patient Form 

is based on the average burden estimate 

of the 2024 burden estimates of existing 

OMB-approved Death Notification 

Registration form with an additional 

0.08 hour per collected form burden to 

reflect an increase in total data fields. 

HRSA specifically requests comments 

on: (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy P. McNulty, 

Deputy Director, Executive Secretariat. 

[FR Doc. 2024–25522 Filed 11–1–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. Given the 

capacity constraints of the venue, the 

public is strongly encouraged to attend 

virtually via NIH videocast. Individuals 

who plan to attend in-person or view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH Videocast at the 

following link: https://

videocast.nih.gov/. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: December 12, 2024. 

Time: 9:00 a.m. to 5:45 p.m. 

Agenda: NIH Director’s Report; Budget 

Update; Legislative Update; RECOVER 2.0 

Early Career Intramural Investigator 

Highlight; ACD Working Group on Diversity 

Update; Accessibility, Disability Inclusion, 

and Disability Research at NIH; NExTRAC 

ENGAGE Update; Scientific Management 

Review Board. Other Business of the 

Committee. 

Date: December 13, 2024. 

Time: 9:00 a.m. to 12:15 p.m. 

Agenda: Cancer Moonshot Update; ABCD 

Update; Alzheimer’s Update; AMP Update 

Other Business of the Committee. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, One Center Drive, 

Bethesda, MD 20892. 

Contact Person: Cyndi Burrus-Shaw, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–2433, email: shawcy@od.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/ 

about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal 

facility will be asked to show one form 

of identification (for example, a 

government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

acd.od.nih.gov, where an agenda and 

any additional information for the 

meeting will be posted when available. 


lotter on DSK11XQN23PROD with NOTICES1
87594 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: October 30, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25584 Filed 11–1–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group; Heart, Lung, and 

Blood Program Project Study Section. 

Date: December 6, 2024. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Address: North Bethesda Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Meeting Format: In Person and Virtual 

Meeting. 

Contact Person: Melissa H. Nagelin, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–R, 

Bethesda, MD 20892, (301) 827–7951, email: 

nagelinmh2@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 30, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25585 Filed 11–1–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; International Research in 

Infectious Diseases (R01 Clinical Trial Not 

Allowed). 

Date: December 2–3, 2024. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Rockville, MD 

20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Rekha Dhanwani, Ph.D., 

Scientific Review Program, National Institute 

of Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, 

Rockville, MD 20892, (240) 627–3076, 

rekha.dhanwani@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 29, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25549 Filed 11–1–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Land Management 

[BLM_NV_FRN_MO4500183047] 

Notice of Availability of the Proposed 

Resource Management Plan 

Amendment and Final Environmental 

Impact Statement for the Rough Hat 

Clark Solar Project in Clark County, NV 

AGENCY: Bureau of Land Management, 

Interior. 

ACTION: Notice of availability. 

SUMMARY: In compliance with the 

National Environmental Policy Act of 

1969, as amended (NEPA), and the 

Federal Land Policy and Management 

Act of 1976, as amended (FLMPA), the 

Bureau of Land Management (BLM) has 

prepared a Proposed Resource 

Management Plan (RMP) Amendment 

and Final Environmental Impact 

Statement (EIS) for the Rough Hat Clark 

Solar Project and by this notice is 

announcing the start of a 30-day protest 

period of the Proposed RMP 

Amendment to the BLM Director. 

DATES: This notice announces the 

opening of a 30-day protest period for 

the Proposed RMP Amendment. Protests 

must be postmarked or electronically 

submitted on the BLM’s National NEPA 

Register site within 30 days of the date 

that the Environmental Protection 

Agency (EPA) publishes its Notice of 

Availability (NOA) in the Federal 

Register. The EPA usually publishes its 

NOAs on Fridays. 

ADDRESSES: The Proposed RMP 

Amendment, Final EIS, and associated 

documents are available on the BLM 

National NEPA Register project website 

at https://eplanning.blm.gov/eplanningui/project/2019992/510. Documents 

pertinent to this proposal may also be 

examined at the Southern Nevada 

District Office, Las Vegas Field Office, 

4701 N Torrey Pines Drive, Las Vegas, 

Nevada 89130. 

Instructions, including addresses, for 

filing a protest with the BLM for the 

Rough Hat Clark Solar Project can be 

found at: https://www.blm.gov/ 

programs/planning-and-nepa/publicparticipation/filing-a-plan-protest and 

at 43 CFR 1610.5–2. 

FOR FURTHER INFORMATION CONTACT: 

Jessica Headen, Project Manager, 

telephone (702) 515–5206, address 

Bureau of Land Management, 4701 N 

Torrey Pines Drive, Las Vegas, NV 

89130. Individuals in the United States 

who are deaf, deafblind, hard of hearing, 

or have a speech disability may dial 711 

(TTY, TDD, or TeleBraille) to access 

telecommunications relay services for 


lotter on DSK11XQN23PROD with NOTICES1